ISPOR Europe 2022 Home
  • About
    • News Center
  • Award Winners
  • Program
    • Program
      • Session
      • Paper
    • Learning Formats
    • Plenary Sessions
    • Spotlight Sessions
    • Posters
    • Educational Symposia & HEOR Theater
    • Program Committee
    • Speaker & Poster Presenter Resources
    • Student Program
  • Exhibits & Sponsorship
    • Sponsor List
    • Exhibitor List
    • Media Partners
  • Photo Gallery
large-circle

ISPOR Europe 2022

6 - 9 November

  • Home
  • Events
  • Past Conferences
  • ISPOR Europe 2022
  • Program
  • Program
  • Session

  • WITHDRAWN The Comparative Effectiveness of Osimertinib as Second-Line or More Egfr-Tki in T790M-Positive Advanced NSCLC Patients: A Systematic Review and Meta-Analysis of Observational Studies

    Nov 7, 2022, 10:00 AM
  • «
  • 2521
  • 2522
  • 2523
  • 2524
  • 2525
  • 2526
  • 2527
  • 2528
  • 2529
  • 2530 (current)
  • »
Quick Links
  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal
  • Antitrust Compliance
  • Code of Ethics
  • Cookie Policy
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy
  • Terms and Conditions

Subscribe

Join ISPOR

ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group